Arun K. Iyer

12.9k total citations · 2 hit papers
131 papers, 9.9k citations indexed

About

Arun K. Iyer is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Arun K. Iyer has authored 131 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 55 papers in Biomaterials and 41 papers in Biomedical Engineering. Recurrent topics in Arun K. Iyer's work include Nanoparticle-Based Drug Delivery (53 papers), RNA Interference and Gene Delivery (38 papers) and Nanoplatforms for cancer theranostics (33 papers). Arun K. Iyer is often cited by papers focused on Nanoparticle-Based Drug Delivery (53 papers), RNA Interference and Gene Delivery (38 papers) and Nanoplatforms for cancer theranostics (33 papers). Arun K. Iyer collaborates with scholars based in United States, India and Saudi Arabia. Arun K. Iyer's co-authors include Samaresh Sau, Prashant Kesharwani, Jun Fang, Khaled Greish, Sushil K. Kashaw, Hiroshi Maeda, Katyayani Tatiparti, Hashem O. Alsaab, Mansoor M. Amiji and Ketki Bhise and has published in prestigious journals such as SHILAP Revista de lepidopterología, Accounts of Chemical Research and PLoS ONE.

In The Last Decade

Arun K. Iyer

130 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploiting the enhanced permeability and retention effect for tumor targeting

2006 1.5k citations Arun K. Iyer, Jun Fang et al. Drug Discovery Today profile →
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

2017 1.3k citations Hashem O. Alsaab, Samaresh Sau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arun K. Iyer United States	49	4.4k	3.6k	3.2k	1.8k	1.1k	131	9.9k
Afsaneh Lavasanifar Canada	52	4.3k 1.0×	4.6k 1.3×	2.1k 0.7×	1.3k 0.7×	944 0.9×	189	10.2k
Haifa Shen United States	46	5.6k 1.3×	4.4k 1.2×	4.4k 1.4×	1.2k 0.7×	1.4k 1.3×	125	11.6k
Tamara Minko United States	57	6.4k 1.5×	6.0k 1.7×	3.7k 1.2×	1.4k 0.8×	649 0.6×	140	13.6k
Horacio Cabral Japan	57	5.7k 1.3×	7.4k 2.1×	6.0k 1.9×	1.5k 0.8×	1.1k 1.0×	184	13.9k
Ronit Satchi‐Fainaro Israel	54	3.3k 0.8×	1.9k 0.5×	2.6k 0.8×	1.4k 0.8×	790 0.7×	158	7.5k
Yongzhuo Huang China	53	4.4k 1.0×	3.3k 0.9×	3.3k 1.0×	1.1k 0.6×	1.6k 1.5×	201	9.5k
Leonard W. Seymour United Kingdom	68	9.1k 2.1×	2.8k 0.8×	2.2k 0.7×	2.9k 1.6×	984 0.9×	254	14.5k
Zhuxian Zhou China	48	3.9k 0.9×	4.3k 1.2×	4.8k 1.5×	740 0.4×	668 0.6×	174	9.6k
Zhonggui He China	58	5.1k 1.2×	5.1k 1.4×	6.2k 2.0×	1.8k 1.0×	1.2k 1.1×	403	13.6k
Jin‐Zhi Du China	42	3.3k 0.7×	5.0k 1.4×	4.7k 1.5×	681 0.4×	854 0.8×	97	8.9k

Countries citing papers authored by Arun K. Iyer

Since Specialization

Citations

This map shows the geographic impact of Arun K. Iyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arun K. Iyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arun K. Iyer more than expected).

Fields of papers citing papers by Arun K. Iyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arun K. Iyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arun K. Iyer. The network helps show where Arun K. Iyer may publish in the future.

Co-authorship network of co-authors of Arun K. Iyer

This figure shows the co-authorship network connecting the top 25 collaborators of Arun K. Iyer. A scholar is included among the top collaborators of Arun K. Iyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arun K. Iyer. Arun K. Iyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rauf, Mohd Ahmar, et al.. (2024). Tau‐targeting nanoparticles for treatment of Alzheimer's disease. SHILAP Revista de lepidopterología. 5(2). 20230137–20230137. 14 indexed citations

Iyer, Arun K., et al.. (2024). An overview of the development of pharmacotherapeutics targeting SARS-CoV-2. Drug Discovery Today. 29(9). 104126–104126. 2 indexed citations

Kumar, Ajay, et al.. (2024). Exhaustive computational studies on pyrimidine derivatives as GPR119 agonist for the development of compounds against NIDDM. SHILAP Revista de lepidopterología. 10(1). 1 indexed citations

Alzhrani, Rami M., Hashem O. Alsaab, Ketki Bhise, et al.. (2021). Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes. Advanced Therapeutics. 4(6). 13 indexed citations

Alzhrani, Rami M., Hashem O. Alsaab, Mohammed Atef, et al.. (2021). CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer. Cancers. 13(4). 898–898. 36 indexed citations

Sau, Samaresh, et al.. (2021). Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers. Materials Today Advances. 10. 100138–100138. 3 indexed citations

Alsaab, Hashem O., Rami M. Alzhrani, Yusuf S. Althobaiti, et al.. (2020). Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine. Cancers. 12(10). 2793–2793. 102 indexed citations

Tatiparti, Katyayani, Mohd Ahmar Rauf, Samaresh Sau, & Arun K. Iyer. (2020). Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor. Molecules. 25(10). 2362–2362. 22 indexed citations

Tatiparti, Katyayani, Mohd Ahmar Rauf, Samaresh Sau, & Arun K. Iyer. (2020). A Biomimetic Drug Delivery System Targeting Tumor Hypoxia in Triple-Negative Breast Cancers. Applied Sciences. 10(3). 1075–1075. 3 indexed citations

10.

Alzhrani, Rami M., et al.. (2019). Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems. Drug Discovery Today. 25(4). 718–730. 45 indexed citations

11.

Tatiparti, Katyayani, et al.. (2018). Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia. International Journal of Molecular Sciences. 19(3). 838–838. 30 indexed citations

12.

Patel, Rajkumar, et al.. (2017). Polymeric microspheres: a delivery system for osteogenic differentiation. Polymers for Advanced Technologies. 28(12). 1595–1609. 12 indexed citations

13.

Gorain, Bapi, Muktika Tekade, Prashant Kesharwani, et al.. (2017). The use of nanoscaffolds and dendrimers in tissue engineering. Drug Discovery Today. 22(4). 652–664. 75 indexed citations

14.

Bhise, Ketki, Sushil K. Kashaw, Samaresh Sau, & Arun K. Iyer. (2017). Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach. International Journal of Pharmaceutics. 526(1-2). 506–515. 87 indexed citations

15.

Tatiparti, Katyayani, Samaresh Sau, Sushil K. Kashaw, & Arun K. Iyer. (2017). siRNA Delivery Strategies: A Comprehensive Review of Recent Developments. Nanomaterials. 7(4). 77–77. 341 indexed citations

16.

Kesharwani, Prashant, Lingxiao Xie, Sanjeev Banerjee, et al.. (2015). Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids and Surfaces B Biointerfaces. 136. 413–423. 153 indexed citations

17.

Kesharwani, Prashant & Arun K. Iyer. (2014). Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discovery Today. 20(5). 536–547. 280 indexed citations

18.

Iyer, Arun K., Jiang He, & Mansoor M. Amiji. (2012). Image-Guided Nanosystems for Targeted Delivery in Cancer Therapy. Current Medicinal Chemistry. 19(19). 3230–3240. 44 indexed citations

19.

Mukerjee, Subhasish, Arun K. Iyer, Vincent Sprenkle, et al.. (2009). Solid Oxide Fuel Cell Stack For Transportation and Stationary Applications. ECS Transactions. 25(2). 59–63. 5 indexed citations

20.

Fang, Jun, Hideaki Nakamura, & Arun K. Iyer. (2007). Tumor-targeted induction of oxystress for cancer therapy. Journal of drug targeting. 15(7-8). 475–486. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact